What is Altimmune's current ratio?

Altimmune (ALT) reported current ratio of 29.6× in Q1 2026.

How has Altimmune's current ratio changed year-over-year?

Altimmune's current ratio increased by 86.5% year-over-year, from 15.8× to 29.6×.

What is the long-term trend for Altimmune's current ratio?

Over 5 years (2020 to 2025), Altimmune's current ratio has grown at a -0.6% compound annual growth rate (CAGR), from 19.2× to 18.5×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Altimmune ALT Current ratio

Current ratio at other companies

Eli LillyLLY

1.5×+0.1×

Merck & Co.MRK

1.3×-0.1×

Madrigal Pharmaceuticals, Inc.MDGL

3.5×-2.4×

Viking TherapeuticsVKTX

5.7×-38.5×

Wave Life SciencesWVE

11.3×+8.3×

MeiraGTx Holdings plcMGTX

0.5×-1.0×

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Where this comes from

Calculated from Altimmune’s reported figures.

total current assets/total current liabilities=29.6×

Based on the most recent quarter.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's current ratio?: Altimmune (ALT) reported current ratio of 29.6× in Q1 2026.
How has Altimmune's current ratio changed year-over-year?: Altimmune's current ratio increased by 86.5% year-over-year, from 15.8× to 29.6×.
What is the long-term trend for Altimmune's current ratio?: Over 5 years (2020 to 2025), Altimmune's current ratio has grown at a -0.6% compound annual growth rate (CAGR), from 19.2× to 18.5×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.